American Society of Clinical Oncology a National Comprehensive Cancer Network vydaly v únoru 2018 nové doporučené postupy na téma řešení nežádoucích účinků imunoterapie. Guideliny vychází pod názvem: Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy.
Plné znění doporučených postupů i podpůrné materiály najdete na stránkách ASCO:
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Igor Puzanov, Cristina A. Reichner, Bianca D. Santomasso, Carole Seigel, Alexander Spira, Maria E. Suarez-Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson, and in collaboration with the National Comprehensive Cancer Network
DOI: 10.1200/JCO.2017.77.6385 Journal of Clinical Oncology - published online before print February 14, 2018
